Our Pipeline

Last updated, April 2021.

Molecule name Indication Discovery (advanced)/ Preclinical Phase I Phase II Phase III Registration Geography
Tirbanibulin
Actinic Keratosis
90 Under registration
EU
UK
MC2-01
Psoriasis
90 Under registration
EU
UK
Lebrikizumab
Atopic dermatitis
56 Fase3
EU
UK
Sarecycline
Acne
48 Fase2
China

Actinic Keratosis Tirbanibulin Under registration eu uk

Psoriasis MC2-01 Under registration eu uk

Atopic dermatitis Lebrikizumab Fase3 eu uk

Acne Sarecycline Fase2 china

Programs in Research & Preclinical